ATRC

Atricure Inc

57.67

Oct 20 • 3:59 PM ET +2.14 (3.85%)

57.67

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Instruments & Supplies USA Mid NASD

Peers: BSX MDT ABT AORT TFX STXS ANGO LIVN JNJ EW

| Held by: IJR VTI IWM VB VBK VXF FESM IJT SPSM IWO

Scroll to Statements

Index	RUT
Market Cap	2.93B
Enterprise Value	2.84B
Income	10.55M
Sales	569.62M
Book/sh	10.15
Cash/sh	3.30
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	1350
IPO	Aug 05, 2005

P/E	266.37
Forward P/E	137.19
PEG	-
P/S	5.15
P/B	5.68
P/C	17.48
P/FCF	55.23
EV/EBITDA	81.72
EV/Sales	4.99
Quick Ratio	3.19
Current Ratio	4.22
Debt/Eq	0.14
LT Debt/Eq	0.14
Option/Short	Yes / Yes

EPS (ttm)	0.22
EPS next Y	0.42
EPS next Q	-0.05
EPS this Y	145.15%
EPS next Y	287.89%
EPS next 5Y	-
EPS past 3/5Y	38.20% 26.83%
Sales past 3/5Y	17.40% 20.95%
EPS Y/Y TTM	128.25%
Sales Y/Y TTM	13.94%
EPS Q/Q	241.25%
Sales Q/Q	12.83%
Earnings	Nov 03 AMC
EPS/Sales Surpr.	10688.24% 1.19%

Insider Own	3.92%
Insider Trans	-3.99%
Inst Own	104.36%
Inst Trans	11.15%
ROA	1.64%
ROE	2.15%
ROIC	1.80%
Gross Margin	75.77%
Oper. Margin	2.44%
Profit Margin	1.85%
SMA20	1.98%
SMA50	8.59%
SMA200	54.77%
Trades

Shs Outstand	50.86M
Shs Float	48.87M
Short Float	9.86%
Short Ratio	4.47
Short Interest	4.82M
52W High	61.70 -6.53%
52W Low	25.36 127.41%
Volatility	3.80% 4.46%
ATR (14)	2.29
RSI (14)	57.55
Beta	1.25
Rel Volume	0.41
Avg Volume	1.08M
Volume	446,400

Perf Week	1.41%
Perf Month	-1.11%
Perf Quarter	72.05%
Perf Half Y	110.71%
Perf YTD	45.78%
Perf Year	53.95%
Perf 3Y	62.18%
Perf 5Y	-20.33%
Perf 10Y	228.23%
Recom	1.67
Target Price	56.50
Prev Close	55.53
Price	57.67
Change %	3.85%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-18-26	Downgrade	Oppenheimer	Outperform → Perform
Feb-11-26	Downgrade	JP Morgan	Overweight → Neutral	$36
Dec-17-24	Resumed	JP Morgan	Overweight	$40
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform	$32
Oct-23-23	Initiated	JMP Securities	Mkt Outperform	$60
Sep-29-23	Initiated	UBS	Buy	$56
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy	$53 → $63
Nov-06-20	Reiterated	Needham	Buy	$63 → $53
Apr-07-20	Initiated	Oppenheimer	Outperform	$45
Feb-06-20	Initiated	BTIG Research	Buy	$42
Jan-24-20	Reiterated	Needham	Buy	$39 → $48
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform	$30
Apr-12-19	Initiated	JP Morgan	Overweight	$37
Oct-04-18	Reiterated	Needham	Buy	$36 → $39
Aug-02-18	Reiterated	Stifel	Buy	$32 → $34
Aug-02-18	Reiterated	Needham	Buy	$32 → $36
Jun-18-18	Reiterated	Needham	Buy	$26 → $32
Apr-27-18	Reiterated	Needham	Buy	$23 → $26
Jan-16-18	Reiterated	Needham	Buy	$25 → $23

Show Previous Ratings

Sep-11-26 11:36AM	AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? (Quartz)
Sep-04-26 07:15PM	Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 (PR Newswire)
Aug-25-26 08:00AM	AtriCure to Participate in the 2026 Wells Fargo Health Care Conference (Business Wire)
Jul-27-26 08:00AM	AtriCure to Participate at Upcoming Investor Conferences (Business Wire) +6.65%
Jul-24-26 01:01AM	AtriCure Inc (ATRC) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Profitability ... (GuruFocus.com) +6.18%
04:12PM	Loading…
Jul-23-26 04:12PM	AtriCure: Q2 Earnings Snapshot (Associated Press)
04:01PM	AtriCure Reports Second Quarter 2026 Financial Results (Business Wire)
Jul-02-26 08:00AM	AtriCure to Announce Second Quarter 2026 Financial Results (Business Wire) +6.93%
Jun-29-26 07:16AM	Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic (MedTech Dive)
May-27-26 03:02PM	Boston Scientific Is the Worst Performing S&P 500 Stock. Here's Why. (Barrons.com)
08:00AM	AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference (Business Wire)
May-06-26 08:30AM	AtriCure, Inc. Q1 2026 Earnings Call Summary (Moby)
May-05-26 04:01PM	AtriCure Reports First Quarter 2026 Financial Results (Business Wire)
Apr-28-26 08:00AM	AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference (Business Wire)
Apr-14-26 08:00AM	AtriCure to Announce First Quarter 2026 Financial Results (Business Wire)
08:00AM	Loading…
Feb-24-26 08:00AM	AtriCure to Participate in the Citizens Life Sciences Conference (Business Wire)
Feb-19-26 07:56AM	COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal (Zacks)
Feb-18-26 01:09PM	GEHC Expands BARDA Collaboration With $35M Boost for AI Ultrasound (Zacks)
10:39AM	Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? (Zacks)
09:51AM	SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy (Zacks)
09:48AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
08:30AM	AtriCure, Inc. Q4 2025 Earnings Call Summary (Moby)
12:01AM	AtriCure Inc (ATRC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-17-26 07:00PM	AtriCure Q4 Earnings Call Highlights (MarketBeat)
07:00PM	Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings (Zacks)
05:35PM	AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:34PM	AtriCure: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Fourth Quarter 2025 and Full Year 2025 Financial Results (Business Wire)
11:20AM	Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel (Zacks)
11:12AM	QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement (Zacks)
10:01AM	Loading…
10:01AM	Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer (Zacks)
Feb-16-26 11:32AM	CareDx Reports Positive Data for AlloHeme in AML and MDS Post HCT (Zacks)
10:52AM	TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial (Zacks)
08:59AM	NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro (Zacks)
Feb-12-26 12:57PM	Stryker Launches T2 Alpha Humerus Nailing System for Fracture Care (Zacks)
Feb-11-26 10:00AM	Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) -13.11%
Feb-10-26 12:20PM	GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency (Zacks)
10:00AM	Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-09-26 10:40AM	GEHC Strengthens AI Fetal Ultrasound via Diagnoly Collaboration (Zacks)
Feb-06-26 10:48AM	MCK Q3 Earnings & Sales Top Estimates, 2026 View Up (Zacks)
Feb-05-26 12:33PM	DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features (Zacks)
10:27AM	CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains (Zacks)
Feb-04-26 12:57PM	Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test (Zacks)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:03AM	GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls (Zacks)
Feb-03-26 01:13PM	GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut (Zacks)
Feb-02-26 09:49AM	Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates (Zacks)
Jan-30-26 01:34PM	GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test (Zacks)
10:25AM	SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption (Zacks)
Jan-29-26 01:32PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
01:28PM	Organon Completes Divesture of JADA System to Laborie Medical (Zacks)
Jan-28-26 11:26AM	QT Imaging & Olea Medical Partner to Enhance Cloud Imaging Platform (Zacks)
Jan-27-26 12:07PM	ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures (Zacks)
08:00AM	AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
07:53AM	CLPT Gets EU MDR Certification for ClearPoint Navigation Software (Zacks)
Jan-23-26 04:14AM	The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices (Zacks)
Jan-22-26 09:32AM	4 High-Efficiency Stocks Poised to Deliver Superior Returns (Zacks)
Jan-20-26 11:04AM	Organon Secures FDA Approval Extending NEXPLANON Use to Five Years (Zacks)
11:00AM	Here's Why You Should Retain CLOV Stock in Your Portfolio for Now (Zacks)
Jan-19-26 12:40PM	Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology (Zacks)
Jan-16-26 12:46PM	Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results (Zacks) -5.79%
12:42PM	DexCom Stock Declines Following Strong Preliminary Q4 Results (Zacks)
09:34AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Jan-15-26 12:09PM	CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 (Zacks) +10.94%
09:36AM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
Jan-14-26 06:24PM	AtriCure CEO Touts $10B AFib and Pain Market, Raises EBITDA Outlook at JPMorgan Conference (MarketBeat)
11:05AM	KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery (Zacks)
Jan-12-26 10:21AM	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 (Business Wire) -9.21%
Jan-09-26 09:15AM	AtriCure, Inc. (ATRC) Soars to 52-Week High, Time to Cash Out? (Zacks)
Jan-06-26 11:39AM	OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device (Zacks)
Dec-29-25 10:57AM	Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA (Zacks)
Dec-24-25 09:40AM	Has AtriCure (ATRC) Outpaced Other Medical Stocks This Year? (Zacks)
Dec-22-25 06:05AM	Analysts See an Over 26% Upside in AtriCure (ATRC) (Insider Monkey)
Dec-19-25 12:00PM	AtriCure (ATRC) Is Up 6.32% in One Week: What You Should Know (Zacks)
Dec-17-25 08:00AM	AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference (Business Wire)
Dec-15-25 10:39AM	Abbott Gains From Lingo CGM's Expansion on Android Platform (Zacks)
Dec-12-25 10:30AM	ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform (Zacks)
10:02AM	CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution (Zacks)
Dec-11-25 08:00AM	AtriCure Announces the First Patients Treated with Novel Dual Energy Platform (Business Wire)
Dec-08-25 09:40AM	Are Medical Stocks Lagging AtriCure (ATRC) This Year? (Zacks)
Nov-25-25 09:55AM	Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade (Zacks)
Nov-20-25 09:40AM	Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? (Zacks)
Nov-18-25 08:00AM	AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
Nov-07-25 09:35AM	AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-06-25 02:16AM	Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Revised) (Zacks)
Nov-04-25 09:40AM	Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year? (Zacks)
Oct-29-25 05:30PM	Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Zacks)
05:10PM	AtriCure (ATRC) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:06PM	AtriCure: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025 (Business Wire)
Oct-28-25 09:46AM	AtriCure Inc (ATRC) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
08:00AM	AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial (Business Wire)
Oct-27-25 08:00AM	AtriCure to Participate in Upcoming Investor Conferences (Business Wire)
Oct-08-25 08:00AM	AtriCure to Announce Third Quarter 2025 Financial Results (Business Wire)
Oct-03-25 05:54AM	Medtronic wins CE mark for Penditure LAA exclusion device (MedTech Dive)
Sep-09-25 08:08AM	Do You Believe in the Upside Potential of Atricure (ATRC)? (Insider Monkey)
08:00AM	AtriCure Announces the Launch of the cryoXT Device for Post-Operative Pain Management Following Amputation (Business Wire)
Aug-20-25 08:00AM	AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference (Business Wire)
Jul-30-25 03:16AM	AtriCure Inc (ATRC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Milestones (GuruFocus.com) +10.72%
Jul-29-25 05:30PM	AtriCure (ATRC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Privitera Salvatore	Chief Technical Officer	Sep 23 '26	Sale	60.00	4,519	271,140	142,745	Sep 24 05:00 PM
SALVATORE PRIVITERA	Officer	Sep 23 '26	Proposed Sale	60.00	4,519	271,140		Sep 23 04:03 PM
GROVES REGINA E	Director	Sep 11 '26	Sale	54.22	5,313	288,071	34,546	Sep 14 05:44 PM
GROVES REGINA E	Director	Sep 10 '26	Proposed Sale	53.66	5,313	285,096		Sep 11 10:59 AM
Privitera Salvatore	Chief Technical Officer	Sep 08 '26	Sale	55.00	3,657	201,135	147,264	Sep 10 09:18 AM
SALVATORE PRIVITERA	Officer	Sep 08 '26	Proposed Sale	55.00	3,657	201,135		Sep 08 04:17 PM
Privitera Salvatore	Chief Technical Officer	Sep 02 '26	Sale	52.50	7,763	407,558	150,921	Sep 04 07:39 AM
SALVATORE PRIVITERA	Officer	Sep 02 '26	Proposed Sale	52.50	7,763	407,558		Sep 02 05:15 PM
Dahlquist Karl S.	Chief Legal Officer	Aug 24 '26	Sale	48.89	9,370	458,099	87,319	Aug 26 06:50 AM
KARL DAHLQUIST	Officer	Aug 24 '26	Proposed Sale	48.89	9,370	458,091		Aug 24 04:11 PM
Prange Karen	Director	Aug 05 '26	Sale	38.80	3,564	138,283	22,809	Aug 07 09:18 AM
Yuen Maggie	Director	Aug 05 '26	Sale	38.42	3,500	134,470	14,015	Aug 07 09:18 AM
MAGGIE YUEN	Director	Aug 05 '26	Proposed Sale	38.42	3,500	134,468		Aug 05 04:16 PM
Prange Karen	Director	Aug 05 '26	Proposed Sale	39.00	3,564	138,996		Aug 05 08:13 AM
Doraiswamy Vinayak	Chief Scientific Officer	Jul 28 '26	Sale	38.88	6,000	233,280	86,511	Jul 30 04:57 PM
WEHRWEIN SVEN	Director	Jul 28 '26	Option Exercise	19.95	25,000	498,750	65,518	Jul 30 04:57 PM
WEHRWEIN SVEN	Director	Jul 28 '26	Sale	37.84	25,000	946,000	40,518	Jul 30 04:57 PM
Noznesky Justin J	Chief Mktg & Strategy Officer	Jul 29 '26	Sale	38.80	6,182	239,862	100,219	Jul 30 04:57 PM
Noznesky Justin J	Officer	Jul 29 '26	Proposed Sale	38.80	6,182	239,882		Jul 29 02:23 PM
VINAYAK DORAISWAMY	Officer	Jul 28 '26	Proposed Sale	38.88	6,000	233,279		Jul 28 04:03 PM
SVEN WEHRWEIN	Director	Jul 28 '26	Proposed Sale	38.58	25,000	964,444		Jul 28 04:03 PM
Prange Karen	Director	May 20 '26	Sale	28.65	3,000	85,950	26,373	May 22 08:57 AM
Prange Karen	Director	May 20 '26	Proposed Sale	28.80	3,000	86,400		May 20 08:24 AM
Doraiswamy Vinayak	Chief Scientific Officer	May 15 '26	Sale	28.13	5,000	140,650	91,875	May 18 04:01 PM
VINAYAK DORAISWAMY	Officer	May 15 '26	Proposed Sale	28.13	5,000	140,674		May 15 05:05 PM
Doraiswamy Vinayak	Chief Scientific Officer	Mar 12 '26	Sale	29.83	5,000	149,150	96,875	Mar 16 08:14 AM
VINAYAK DORAISWAMY	Officer	Mar 12 '26	Proposed Sale	29.83	5,000	149,152		Mar 12 04:38 PM
WHITE ROBERT S.	Director	Mar 10 '26	Option Exercise	14.99	10,000	149,900	122,174	Mar 12 08:52 AM
WEHRWEIN SVEN	Director	Nov 24 '25	Option Exercise	19.95	5,033	100,408	39,407	Nov 26 04:43 PM
WEHRWEIN SVEN	Director	Nov 25 '25	Option Exercise	19.95	4,967	99,092	39,341	Nov 26 04:43 PM
WEHRWEIN SVEN	Director	Nov 25 '25	Sale	38.00	4,967	188,746	34,374	Nov 26 04:43 PM
WEHRWEIN SVEN	Director	Nov 24 '25	Sale	37.32	5,033	187,832	34,374	Nov 26 04:43 PM
Noznesky Justin J	Chief Mktg & Strategy Officer	Nov 26 '25	Sale	37.29	5,166	192,640	78,798	Nov 26 04:41 PM
Noznesky Justin J	Officer	Nov 26 '25	Proposed Sale	37.29	5,166	192,642		Nov 26 11:48 AM
SVEN WEHRWEIN	Director	Nov 25 '25	Proposed Sale	38.00	4,967	188,746		Nov 25 04:06 PM
Yuen Maggie	Director	Nov 21 '25	Sale	35.72	3,000	107,160	11,371	Nov 25 09:01 AM
SVEN WEHRWEIN	Director	Nov 24 '25	Proposed Sale	37.32	5,033	187,854		Nov 24 05:41 PM
MAGGIE YUEN	Director	Nov 21 '25	Proposed Sale	35.72	3,000	107,158		Nov 21 05:53 PM

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

CEOMr. Michael H. Carrel

Chief Financial OfficerMs. Angela L. Wirick

Chief Operating OfficerMr. Douglas J. Seith

Chief Technical OfficerMr. Salvatore Privitera J.D.

Chief Marketing & Strategy OfficerMr. Justin J. Noznesky

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ATRC

Atricure Inc

Upgrade your Finviz experience